课题基金 / 基金详情

Personalized Clinical Decision Support to Improve Participation in Hospital at Home

Personalized Clinical Decision Support to Improve Participation in Hospital at Home
个性化临床决策支持,提高在家就医的参与度
批准号:
10428461
负责人:
Marc Kowalkowski
金额:
$10.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-06-15 至 2023-05-31

项目摘要

项目成果

Marc Kowalkowski的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Inpatient hospitalization is costly – accounting for $1.1 trillion in health care spending annually in the United States – and is associated with high morbidity and mortality risks. Hospital at Home (HaH) is an alternative care model where care teams provide acute hospital-level care in a patient’s home. Despite decades of data that support HaH efficacy relevant to key patient-centered outcomes, barriers to HaH participation limit its widespread adoption and population health impact. Our central hypothesis is that providers and patients require Clinical Decision Support (CDS) integrating data from disparate sources and a Shared Decision Making (SDM) framework to help inform point-of-care decisions regarding HaH and surmount low participation rates. The overarching goal of our work is to improve value-driven care by helping patients engage in the decision of which acute-level care option best meets their needs. The objective of this study is to evaluate whether a Health Information Technology (IT)-enabled SDM solution incorporating expected patient outcomes and preferences and deployed at the point-of-care improves patient and provider participation in HaH as a care model. To achieve this objective, we will: 1) characterize patient, caregiver, and provider perceptions of the risk tradeoffs, needs, and care preferences for HaH; 2) partner with patients, caregivers, and providers to iteratively design Hospital-level Outpatient Management Evaluation and Decision Support (HOME-DS), a Health IT- enabled SDM solution that incorporates risk-model probabilities and patient and caregiver preferences; and 3) evaluate the feasibility of implementing HOME-DS in acute care and establish the acceptance rate of HaH. We will focus HOME-DS on adults aged 18 and older hospitalized with suspected pneumonia, a prevelant condition that has been commonly included in HaH models. We will apply the previously validated and broadly accepted Pneumonia Severity Index (PSI) as the quantitative risk score input for HOME-DS. User personas and needs for the initial HOME-DS prototype will be defined through key informant interviews with patients hospitalized with pneumonia, their caregivers, and providers (Aim1); user-centric design principles will further guide iterative development of the HOME-DS prototype (Aim 2); and we will test the feasibility of implementing HOME-DS in acute care to guide patient and caregiver decision making in selecting hospital level care in the home or traditional hospital (Aim 3). We hypothesize HOME-DS is feasible to implement within the provider workflow for hospital admission and can yield participation rates in HaH of 50%. The proposed project will engage a heterogeneous population with pneumonia, as this is a population with substantial acute care utilization costs and a large gap in understanding implementation challenges to explain why alternatives to traditional hospitalization are not used more widely. Results will demonstrate the value of Health IT that integrates clinical data with patient preferences to promote effective SDM enhancing patient-centered acute care options.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Healthcare Access and Sequelae Evaluation
  • 批准号:
    10320654
  • 项目类别:
  • 资助金额:
    $14.66万
  • 财政年份:
    2019
  • 负责人:
    Marc Kowalkowski
  • 依托单位:
A Sepsis Transition Program to Reduce Morbidity and Mortality in High Risk Individuals
  • 批准号:
    9982449
  • 项目类别:
  • 资助金额:
    $61.35万
  • 财政年份:
    2019
  • 负责人:
    Marc Kowalkowski
  • 依托单位:
A Sepsis Transition Program to Reduce Morbidity and Mortality in High Risk Individuals
COVID-19 Healthcare Access and Sequelae Evaluation
  • 批准号:
    10621400
  • 项目类别:
  • 资助金额:
    $14.63万
  • 财政年份:
    2019
  • 负责人:
    Marc Kowalkowski
  • 依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data